Brimonidine Tartrate 2.00 mg + Timolol 5.00 mg

BRIMOCOM is a fixed dose combination eye drop medication that contains Timolol and Brimonidine Tartrate. Timolol is a beta blocker that reduces the production of fluid in the eye, thereby lowering intraocular pressure. Brimonidine Tartrate is an alpha agonist that decreases eye pressure by reducing fluid production and increasing fluid drainage. This combination is primarily used for the treatment of open-angle glaucoma or ocular hypertension, conditions that can lead to increased pressure in the eye and potential vision loss. BRIMOCOM is prescribed to help manage and reduce intraocular pressure, thereby preventing optic nerve damage and preserving vision.

Instill BRIMOCOM eye drops into the affected eye(s) as directed by your doctor. Avoid touching the dropper tip to any surface to prevent contamination. Do not use if the solution color has changed or if it contains particles.

Allopathic

The contents and information provided here are solely intended to provide a general overview of the products and medicines and must be used for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. The information contained herein should not be used as a substitute for the advice of a qualified physician. For all queries or doubts related to your medical condition, we highly recommend that you consult your registered medical practitioner.